ENDOMIX is a pioneering research project dedicated to uncovering the true impact of Endocrine Disrupting Chemicals (EDCs) and their mixtures on human health, bridging the gap between science and policy to inform regulation and protect vulnerable populations. Employing an interdisciplinary approach, ENDOMIX investigates the complex interactions of EDCs with the immune system, with the goal of providing new insights and recommendations to minimize exposure and prevent adverse health effects. By focusing on mixtures of real-life EDCs, vulnerable life stages and advanced research methodologies, ENDOMIX aims to revolutionize the understanding of immunotoxicity and its implications for human health.
| Funding agency |
European Comission |
| Programme |
Horizon Europe |
| Full name | Understanding how endocrine disruptors and chemical mixtures of concern target the immune system to trigger or perpetuate disease |
| Reference | 101136566 |
| Acronym | ENDOMIX |
| Involvement | Affiliated Entity |
| Scientific lead | Sabrina Llop Pérez |
| Period | 2024-2027 |
| Budget | 32.250€ |
| Web | https://endomix.eu/ |

